Observations placeholder
Is low dose of estrogen beneficial for prevention of glaucoma?
Identifier
017894
Type of Spiritual Experience
Background
A description of the experience
Med Hypotheses. 2012 Sep;79(3):377-80. doi: 10.1016/j.mehy.2012.05.041. Epub 2012 Jun 22.
Is low dose of estrogen beneficial for prevention of glaucoma?
Wei X1, Cai SP, Zhang X, Li X, Chen X, Liu X.
- 1Ophthalmic Laboratories and Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Abstract
Glaucoma, as characterized by accelerated retinal ganglion cell (RGC) death and cupping of optic nerve head (ONH), is one of the leading causes of blindness worldwide. Elevated intraocular pressure (IOP) is generally considered as a major risk factor in the pathogenesis of glaucoma.
Previous studies showed that glaucoma caused decrease in collagen and elastin density in several ocular tissues, such as lamina cribrosa, peripapillary sclera and cornea, and resulted in reduced elasticity and compliance of these tissues.
It is known that estrogen has protective effects against glaucoma, yet the underlying mechanism still remains obscure.
Prior researches have provided evidences showing that the estrogen receptors (ERs) express in a variety of the ocular tissues. Estrogen activates the synthesis of collagen fiber and improves the compliance of these tissues.
This leads to a reasonable postulation that increased estrogen may result in a higher content of the collagen fibers and enhanced flexibility of the whole eye, which would therefore decrease IOP. Particularly, the increase in the amounts of collagen fibers at lamina cribrosa improves its compliance, which in turn relieves its compression on RGC axons. Therefore, even at the same IOP level, the softening of cribriform foramina yields a more flexible environment for the RGCs to survive.
We therefore hypothesize that estrogen at proper dosage can be considered as a potential therapy for glaucoma since it is able to prevent the eye from glaucomatous damage and lower IOP, especially for those menopausal women with glaucoma.
Copyright © 2012 Elsevier Ltd. All rights reserved.
PMID: 22727818
The source of the experience
PubMedConcepts, symbols and science items
Concepts
Symbols
Science Items
Activities and commonsteps
Activities
Overloads
Estrogen imbalanceEye disease treatments
Eye disease treatments - glaucoma
Eye disease treatments - macular degeneration
Menopause
Suppressions
Blindness, macular degeneration and other sight impairmentPhytoestrogens